WT1 and acute myeloid leukemia: The highest levels of WT1 expression were found in the M3 AML subgroup (according to French-American-British, FAB, classification) and were linked to a failure of achieving complete remission (CR), shorter overall survival (OS), and shorter progression-free survival [13,14].